BRIEF-Shenzhen Hepalink Pharma Gets Regulatory Approval For Hong Kong IPO

Shenzhen Hepalink Pharmaceutical Group Co Ltd: * SAYS IT GETS CHINA SECURITIES REGULATOR’S APPROVAL FOR INITIAL H-SHARE OFFERING IN HONG KONG Source text in Chinese: bit.ly/2KjxFCl Further company …
( read original story …)